Thursday, September 16, 2010 12:49:31 PM
Today's SEC filing has Mr. James Barry Somervail of WDRP, HRRN and Orrwell fame has resigned from MRES...
What a surprise...LOL...
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 15, 2010 Mr. Barry Somervail resigned as the President, CEO and Director of Neuro-Biotech Corp. (the “Company”). Mr. Somervail decided to resign as a result of the Company’s new business ventures in the field of neuroscience; however, he is not resigning as the result of a disagreement on any matter relating to the Company’s operations, policies or practices.
On September 15, 2010 Mr. Claude Poulin was appointed the President and CEO of the Company and elected Director. Mr. Poulin is 71 years of age, a general practitioner with over 40 years of experience and has his own cabinet in Lachute, Quebec Canada.
8k Filing: http://secwatch.com/filings/view.jsp?formid=7371758&source=rss
Orrwell: http://news.google.ca/newspapers?id=qdEyAAAAIBAJ&sjid=oO8FAAAAIBAJ&pg=1393,2307419&dq=james+barry+somervail&hl=en
Recent MRES News
- M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board • InvestorsHub NewsWire • 07/19/2023 01:18:56 PM
- M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits • InvestorsHub NewsWire • 07/14/2023 12:52:00 PM
- M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access • InvestorsHub NewsWire • 07/06/2023 01:38:23 PM
- Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing • InvestorsHub NewsWire • 07/05/2023 02:04:17 PM
- M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX • InvestorsHub NewsWire • 06/26/2023 12:45:19 PM
- M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines • InvestorsHub NewsWire • 06/16/2023 12:30:00 PM
- M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization • InvestorsHub NewsWire • 06/14/2023 12:00:00 PM
- Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions • InvestorsHub NewsWire • 06/07/2023 02:06:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM